GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jeil Pharma Holdings Inc (XKRX:002620) » Definitions » Ending Cash Position

Jeil Pharma Holdings (XKRX:002620) Ending Cash Position : ₩33,456 Mil (As of Mar. 2024)


View and export this data going back to 1988. Start your Free Trial

What is Jeil Pharma Holdings Ending Cash Position?

Jeil Pharma Holdings's Ending Cash Position for the quarter that ended in Mar. 2024 was ₩33,456 Mil.

Jeil Pharma Holdings's quarterly Ending Cash Position increased from Sep. 2023 (₩34,537 Mil) to Dec. 2023 (₩37,039 Mil) but then declined from Dec. 2023 (₩37,039 Mil) to Mar. 2024 (₩33,456 Mil).

Jeil Pharma Holdings's annual Ending Cash Position increased from Dec. 2021 (₩28,581 Mil) to Dec. 2022 (₩34,760 Mil) and increased from Dec. 2022 (₩34,760 Mil) to Dec. 2023 (₩37,039 Mil).

Jeil Pharma Holdings Ending Cash Position Historical Data

The historical data trend for Jeil Pharma Holdings's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jeil Pharma Holdings Ending Cash Position Chart

Jeil Pharma Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 21,236.95 20,183.39 28,580.78 34,759.51 37,038.63

Jeil Pharma Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 33,297.34 43,044.78 34,536.57 37,038.63 33,456.08

Jeil Pharma Holdings Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Jeil Pharma Holdings's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=34759.506+2279.122
=37,039

Jeil Pharma Holdings's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=37038.627+-3582.551
=33,456

Jeil Pharma Holdings Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Jeil Pharma Holdings's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Jeil Pharma Holdings (XKRX:002620) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jeil Pharma Holdings Inc (XKRX:002620) » Definitions » Ending Cash Position
Comparable Companies
XKRX:176750 XKRX:214390 XKRX:023910 XKRX:082800 XKRX:061250 XKRX:002390 XKRX:006620 XKRX:003120 XKRX:002210 XKRX:389470 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
745-5, Banpo-dong, Seocho-gu, Seoul, KOR, 137-810
Website
https://www.jeilpharm.co.kr
Jeil Pharma Holdings Inc is involved in manufacture and distribution of pharmaceutical products. The company mainly produces finished pharmaceutical products and active pharmaceutical ingredients. It has categorized its products in Antibiotic, Oncology, Cardiovascular, Gastrointestinal, Urology, Respiratory etc. The firm's manufacturing facility and research and development institute located at Yongin-si, Gyeonggi-do in Korea.

Jeil Pharma Holdings (XKRX:002620) Headlines

No Headlines